POLYPOIDAL CHOROIDAL VASCULOPATHY
Clinical trials for POLYPOIDAL CHOROIDAL VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new POLYPOIDAL CHOROIDAL VASCULOPATHY trials appear
Sign up with your email to follow new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for blinding eye disease shows promise in trial
Disease control CompletedThis study tested two treatments for polypoidal choroidal vasculopathy (PCV), an eye condition that can lead to blindness. 60 patients received either eye injections of aflibercept alone or aflibercept combined with a special light therapy (reduced-fluence PDT). The goal was to s…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: NA • Sponsor: Singapore National Eye Centre • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Eye disease patients tracked for 5 years to see how often it returns
Knowledge-focused CompletedThis study followed 72 people with polypoidal choroidal vasculopathy (PCV), an eye condition that can cause vision loss, for 5 years after their first treatment. Researchers wanted to see how often the disease comes back, what treatments were needed, and if early treatment result…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated May 26, 2026 11:47 UTC